C5AR1 and COVID-19: Interestingly, in those patients with a more severe disease, C5a levels remained elevated weeks after hospital discharge, and were associated with the persistence of respiratory symptoms, suggesting that modulation of complement activation may be an effective therapeutic strategy for the treatment of COVID-19 patients with long-term respiratory problems.